Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alirocumab
amgen
biotech
boston blog main
evolocumab
heart attack
2
×
inclisiran
life sciences
medicines co.
national blog main
new york blog main
new york top stories
regeneron pharmaceuticals
stroke
alnylam pharmaceuticals
boston top stories
boulder/denver blog main
boulder/denver top stories
cardiac
cardiovascular
cause of death
cedar-sinai
cholesterol
circulation
clinical studies
clinical trials
david maron
detroit blog main
detroit top stories
drugs
esperion pharmaceuticals
evercore isi
fh foundation
heart disease
indiana blog main
indiana top stories
joseph swartz
ldl
medco
mt sinai hospital
What
cholesterol
2
×
drug
lowering
new
alnylam
based
data
drugs
evidence
expensive
faces
financial
foe
healthcare
heart
hint
inhibitors
known
lasting
long
looms
medco
medicines
partner
pcsk
pharmaceuticals
presented
reckoning
remember
rna
supporting
supposed
term
tough
touts
use
wave
Language
unset
Current search:
cholesterol
×
" heart attack "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms